×
About 665 results

ALLMedicine™ Breast Examination Center

Research & Reviews  193 results

Management of breast complaints and high-risk lesions.
https://doi.org/10.1016/j.bpobgyn.2022.03.017
Best Practice & Research. Clinical Obstetrics & Gynaecology; Pleasant V

May 16th, 2022 - Benign breast disease including palpable breast mass, mastalgia, skin changes, and nipple discharge are common gynecologic symptoms. Practitioners should be well versed in the components of clinical breast care. Workup begins with taking a thoroug...

Interventions to increase mammography screening uptake among women living in low-income...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968630
BMJ Open; Nduka IJ, Ejie IL et. al.

Apr 1st, 2022 - Breast cancer is the most prevalent cancer and the second leading cause of cancer-related deaths among women in low and middle-income countries (LMICs), including sub-Saharan Africa. Mammography screening is the most effective screening method for...

Trivandrum Breast Cancer Screening Trial
https://clinicaltrials.gov/ct2/show/NCT05301296

Mar 29th, 2022 - The study population consisted of 274 administrative regions (clusters) in Trivandrum district, Kerala, southern Indian. 133 clusters were randomly assigned to the intervention arm (3 rounds of clinical breast examination conducted 3 years apart) ...

Breast Cancer
http://emedicine.medscape.com/article/1947145-overview

Mar 25th, 2022 - Practice Essentials Breast cancer is the common term for a set of breast tumor subtypes with distinct molecular and cellular origins and clinical behavior. Most of these are epithelial tumors of ductal or lobular origin (see the image below). Worl...

The iBreastExam versus clinical breast examination for breast evaluation in high risk a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102465
The Lancet. Global Health; Mango VL, Olasehinde O et. al.

Mar 19th, 2022 - The iBreastExam electronically palpates the breast to identify possible abnormalities. We assessed the iBreastExam performance compared with clinical breast examination for breast lesion detection in high risk and symptomatic Nigerian women. This ...

see more →

Guidelines  5 results

ACR Appropriateness Criteria® Palpable Breast Masses.
https://doi.org/10.1016/j.jacr.2017.02.033
Journal of the American College of Radiology : JACR; , Moy L et. al.

May 6th, 2017 - Breast cancer is the most common female malignancy and the second leading cause of female cancer death in the United States. Although the majority of palpable breast lumps are benign, a new palpable breast mass is a common presenting sign of breas...

Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the Ameri...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831582
JAMA Oeffinger KC, Fontham ET et. al.

Oct 27th, 2015 - Breast cancer is a leading cause of premature mortality among US women. Early detection has been shown to be associated with reduced breast cancer morbidity and mortality. To update the American Cancer Society (ACS) 2003 breast cancer screening gu...

Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.
https://doi.org/10.7326/0003-4819-151-10-200911170-00008
Annals of Internal Medicine;

Nov 19th, 2009 - Update of the 2002 U.S. Preventive Services Task Force (USPSTF) recommendation statement on screening for breast cancer in the general population. The USPSTF examined the evidence on the efficacy of 5 screening modalities in reducing mortality fro...

Guideline implementation for breast healthcare in low- and middle-income countries: dia...
https://doi.org/10.1002/cncr.23840
Cancer Shyyan R, Sener SF et. al.

Oct 7th, 2008 - A key determinant of breast cancer outcome in any population is the degree to which newly detected cancers can be diagnosed correctly so that therapy can be selected properly and provided in a timely fashion. A multidisciplinary panel of experts r...

2008 update of the guideline: early detection of breast cancer in Germany.
https://doi.org/10.1007/s00432-008-0450-y
Journal of Cancer Research and Clinical Oncology; Albert US, Altland H et. al.

Jul 29th, 2008 - The goal of the 2008 updated guideline: early detection of breast cancer in Germany is to support physicians as well as healthy and affected women in the decision-making process involved in the diagnostic chain for the early detection of breast ca...

see more →

Clinicaltrials.gov  7 results

Trivandrum Breast Cancer Screening Trial
https://clinicaltrials.gov/ct2/show/NCT05301296

Mar 29th, 2022 - The study population consisted of 274 administrative regions (clusters) in Trivandrum district, Kerala, southern Indian. 133 clusters were randomly assigned to the intervention arm (3 rounds of clinical breast examination conducted 3 years apart) ...

[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma
https://clinicaltrials.gov/ct2/show/NCT04252859

Sep 22nd, 2021 - According to the National Comprehensive Cancer Network (NCCN) 2018 guidelines FDG-PET/CT may be performed as an alternative to a contrast-enhanced CT of the chest, abdomen and pelvis and Tc-99m MDP bone scan for evaluation of distant metastatic di...

Letrozole Versus Gonadotropins in Clomiphene Citrate Resistance
https://clinicaltrials.gov/ct2/show/NCT04834791

Apr 8th, 2021 - This study included 70 patients enrolled according inclusion and exclusion criteria. The inclusion criteria were (a) Infertility lasting one year or more in presence of regular intercourse, (b) Patients' age between 20-35years (c) Normal semen ana...

Dynamic Infrared Thermography in Breast Cancer Diagnostics
https://clinicaltrials.gov/ct2/show/NCT02829021

Jul 12th, 2016 - This study evaluate diagnostic accuracy of dynamic infrared thermography compared to mammography (reference test) in breast cancer diagnostics. Dynamic infrared thermography (DIRT) is an imagine procedure offering a non-invasive, painless examinat...

Colombian Screening Mammography Project
https://clinicaltrials.gov/ct2/show/NCT02337582

Jan 13th, 2015 - A cluster randomized controlled trial was performed in Bogotá, Colombia between 2007-2008 to evaluate the effects of an opportunistic (hospital-based) screening program (intervention) vs. usual care (control) in which 26 clinics were randomized to...

see more →

News  60 results

Patient Profile 1: Frontline Therapy for HER2+ mBC
https://www.onclive.com/view/patient-profile-1-frontline-therapy-for-her2-mbc

Apr 17th, 2022 - Transcript: Neil Iyengar, MD: That being said, I’d like to get to our cases. I think you have a really interesting case that we’d like to discuss today. Could you go ahead and tell us about your patient? Milana Dolezal, MD, MSci: My patient or...

ACP Releases Breast Cancer Screening Guidance Statements for Asymptomatic, Average-Risk Women
https://www.onclive.com/view/acp-releases-breast-cancer-screening-guidance-statements-for-asymptomatic-average-risk-women

Oct 6th, 2021 - Ana Maria Lopez, MD For women at average risk for breast cancer who are between the ages of 40 and 49 years, clinicians should have a personalized approach on whether their patients should be screened with mammography prior to the age of 50, acco...

Canadian Breast Screening Study Reignites Controversy Over Mammograms
https://www.onclive.com/view/canadian-breast-screening-study-reignites-controversy-over-mammograms

Dec 20th, 2020 - Patrick I. Borgen, MD The large Canadian study that has caused a stir by indicating that mammograms are of no use in women aged 40 to 59 years, and in fact can lead to over-diagnosis of breast cancer, is flawed and misleading, according to the pr...

Regular MRI Screening Suggested for Women With Familial Breast Cancer Risk
https://www.medscape.com/viewarticle/935317

Aug 7th, 2020 - NEW YORK (Reuters Health) - Women ages 35-60 with a family history of breast cancer can be cost-effectively screened with magnetic resonance imaging (MRI) every 18 months, an economic evaluation modeling study suggests. The team's previous study, ...

Regular MRI Screening Suggested for Women With Familial Breast Cancer Risk
https://www.staging.medscape.com/viewarticle/935317

Aug 7th, 2020 - NEW YORK (Reuters Health) - Women ages 35-60 with a family history of breast cancer can be cost-effectively screened with magnetic resonance imaging (MRI) every 18 months, an economic evaluation modeling study suggests. The team's previous study, ...

see more →

Patient Education  1 results see all →